Cancer of the Heart : An Insight

Linkedin : https://www.linkedin.com/in/shaziya-javid-746b71222

Although uncommon, cardiac neoplasms are a treatable form of the disease if found early. Due to the development of procedures like 2D and 3D echocardiography, MRI, etc., viscus tumors' have become more prominent in recent years. These cardiac tumor's are separated into primary and secondary cardiac tumours, as well as benign and malignant cardiac tumor's. Primary heart tumours tend to occur more frequently than secondary cardiac tumours. Anywhere in the body where the heart is involved, the secondary tumour might develop. Sarcomas are the most prevalent malignant tumours, along with certain fibromas, rhabdosarcomas, and leiomyosarcomas. Both men and women are equally affected by primary sarcoma, which has vague symptoms. Due to these factors, there is a growing demand for genomic testing that aids in spotting the mutation that leads to the particular type of cardiac neoplasm and it additionally helps to screen the mutated sequence and stop it from being inherited.

As cancer incidence increases, metastatic malignancy to the heart acquires more significance for diagnostic and therapeutic purposes. Evidently, Boneti originally described the illness around 1700. Any or all of the heart's components may be affected by neoplastic growths. Most often, embolic tumour cells enter the smaller coronary channels through a hematogenous route, from which they invade the heart. More rarely, fibrin develops on tumour cells released into the venous system, encouraging tumour growth and producing a tumour thrombus that may invade the heart chambers. Another way that tumours might get to the heart is by growing directly from an intrathoracic malignancy. Finally, a tumour may travel retrogradely through the tracheobronchial and mediastinum to the heart. Microscopically, carcinomatous lymphangitis, a condition in which the superficial lymph vessels of the heart are packed with cancerous cells.

Heart metastases typically resemble the main lesion in terms of pathology and are microscopically tiny, hard, and nodular. Infrequent is necrosis. Even in the absence of invasion, leukemic cells may still be visible in the lumen of smaller vessels. Leukemia typically results in diffuse and localised infiltrations radiating around blood vessels. On occasion, the lumen of coronary vessels may also contain Emboli from various malignancies.

Scheme of interacting factors between heart failure (HF), coronary heart disease (CHD), cancer growth, and muscle atrophy.

References:

1. https://link.springer.com/article/10.1007/s12032-022-01761-5

2. https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.22.3.474

3. https://www.frontiersin.org/articles/10.3389/fphys.2021.729713/full